Thursday, 14 August 2014

Experimental Ebola drug Zmapp arrives in Africa but only TWELVE doses


Liberia is facing an excruciating choice - deciding which handful of Ebola patients will receive an experimental drug that could prove either life-saving or life-threatening.
ZMapp, the untested Ebola drug, arrived in the West African country late yesterday.
Liberia's Minister of Foreign Affairs, Augustine Ngufuan, couriered the two boxes of Zmapp himself on a commercial flight from the U.S. to Monrovia, where it was unloaded at a VIP terminal. 

No comments:

Post a Comment